INV21 Low Dose
INV-EVR-101
Phase 1 mab completed
Quick answer
INV21 Low Dose for Hand, Foot and Mouth Disease is a Phase 1 program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Hand, Foot and Mouth Disease
- Phase
- Phase 1
- Modality
- mab
- Status
- completed